Infection of Dendritic Cells by Lymphocytic Choriomeningitis Virus
Overview
Microbiology
Authors
Affiliations
Dendritic cells (DCs) comprise the major antigen-presenting cells (APCs) of the host, uniquely programmed to stimulate immunologically naïve T lymphocytes. Viruses that can target and disorder the function of these cells enjoy a selective advantage. The cellular receptor for lymphocytic choriomeningitis virus (LCMV), Lassa fever virus (LFV), and several other arenaviruses is alpha-dystroglycan (alpha-DG). Among cells of the immune system, CD11c+ and DEC-205+ DCs primarily and preferentially express alpha-DG. By selection, strains and variants of LCMV generated as quasi-species that bind alpha-DG with high affinity replicate in the majority of CD11c+ and DEC-205+ (>75%) DCs, causing a generalized immunosuppression, and establish a persistent infection. In contrast, viral strains and variants that bind with low affinity to alpha-DG display minimal replication in CD11c+ and DEC-205+ DCs (<10%), rarely replicate in the white pulp, and generate a robust anti-LCMV CTL response that clears the virus infection. Hence, receptor-virus interaction on DCs in vivo is an essential step in the initiation of virus-induced immunosuppression and viral persistence. Investigation into the mechanism of how virus-infected DCs cause immunosuppression reveals loss of MHC class II surface expression and costimulatory molecules on surface of such DCs. As a consequence DCs are unable to act as APCs, initiate immune responses, and have a defect in migration into the T cell area. These data indicate that LCMV infection influences DC maturation and migration, leading to decreased T cell stimulatory capacity of DCs, events essential for the initiation of immune responses. Because several other viruses known to cause immunosuppression (HIV, measles) interact with DCs, the observations noted here are likely a common selective mechanism by which viruses also are able to evade the host's immune system.
Bullock C, Wang L, Ware B, Wagoner N, Ohara R, Liu T mBio. 2024; 15(12):e0293024.
PMID: 39535221 PMC: 11633147. DOI: 10.1128/mbio.02930-24.
Johnson D, Khakhum N, Wang M, Warner N, Jokinen J, Comer J Viruses. 2024; 16(4).
PMID: 38675975 PMC: 11053560. DOI: 10.3390/v16040635.
Autoimmunity-associated allele of tyrosine phosphatase gene PTPN22 enhances anti-viral immunity.
Orozco R, Marquardt K, Pratumchai I, Shaikh A, Mowen K, Domissy A PLoS Pathog. 2024; 20(3):e1012095.
PMID: 38512979 PMC: 10987006. DOI: 10.1371/journal.ppat.1012095.
Cytotoxic CD4 T cells in chronic viral infections and cancer.
Malyshkina A, Bruggemann A, Paschen A, Dittmer U Front Immunol. 2023; 14:1271236.
PMID: 37965314 PMC: 10642198. DOI: 10.3389/fimmu.2023.1271236.
Lee I, Joo Y, Jeon H, Kim J, Seo Y, Hong S Genes Genomics. 2023; 45(9):1117-1126.
PMID: 37418075 DOI: 10.1007/s13258-023-01421-6.